CD69-mediated pathway of lymphocyte activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor alpha/beta.
about
Identification and molecular cloning of p75/AIRM1, a novel member of the sialoadhesin family that functions as an inhibitory receptor in human natural killer cellsMolecular cloning, expression, and chromosomal localization of the human earliest lymphocyte activation antigen AIM/CD69, a new member of the C-type animal lectin superfamily of signal-transmitting receptorsMolecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicityRecruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptorNKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysisp46, a novel natural killer cell-specific surface molecule that mediates cell activationIdentification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cellsCD34+ cells cultured in stem cell factor and interleukin-2 generate CD56+ cells with antiproliferative effects on tumor cell lines.Modulation of NK cell function by genetically coupled C-type lectin-like receptor/ligand pairs encoded in the human natural killer gene complexSoluble recombinant CD69 receptors optimized to have an exceptional physical and chemical stability display prolonged circulation and remain intact in the blood of miceFunctional role for Syk tyrosine kinase in natural killer cell-mediated natural cytotoxicityDifferential activation of NK cells by influenza A pseudotype H5N1 and 1918 and 2009 pandemic H1N1 virusesCD69 and regulation of the immune function.Persistence of Activated and Adaptive-Like NK Cells in HIV+ Individuals despite 2 Years of Suppressive Combination Antiretroviral Therapy.Turning on natural killer cells.CD94 defines phenotypically and functionally distinct mouse NK cell subsets.Transcriptional regulation of the gene encoding the human C-type lectin leukocyte receptor AIM/CD69 and functional characterization of its tumor necrosis factor-alpha-responsive elements.Relevance of the mevalonate biosynthetic pathway in the regulation of bone marrow mesenchymal stromal cell-mediated effects on T-cell proliferation and B-cell survivalSuppression of natural killer cells by sorafenib contributes to prometastatic effects in hepatocellular carcinomaProtective immunity against experimental pulmonary cryptococcosis in T cell-depleted mice.Trypanosoma cruzi-induced immunosuppression: selective triggering of CD4+ T-cell death by the T-cell receptor-CD3 pathway and not by the CD69 or Ly-6 activation pathwayNatural killer cytolytic activity is associated with the expression of killer cell immunoglobulin-like receptors on peripheral lymphocytes in humanPrevention of NKT cell activation accelerates cutaneous wound closure and alters local inflammatory signalsInnate Immune Activity Correlates with CD4 T Cell-Associated HIV-1 DNA Decline during Latency-Reversing Treatment with Panobinostat.A lymphocyte-activating monoclonal antibody induces regression of human tumors in severe combined immunodeficient miceβ-Adrenergic receptor mediated increases in activation and function of natural killer cells following repeated social disruptionEnhanced antitumor immunity in mice deficient in CD69.2B4 acts as a non-major histocompatibility complex binding inhibitory receptor on mouse natural killer cells.Adhesion of tumour-infiltrating lymphocytes to endothelium: a phenotypic and functional analysis.C-type lectin-like receptors on myeloid cells.Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity.NK cell autoreactivity and autoimmune diseases.Structural basis for recognition of cellular and viral ligands by NK cell receptors.Revisiting the Prominent Anti-Tumoral Potential of Pre-mNK Cells.Attenuation of lung inflammation and fibrosis in CD69-deficient mice after intratracheal bleomycin.Molecular cloning and characterization of porcine indoleamine 2, 3-dioxygenase and its expression in various tissues.The histone deacetylase inhibitor valproic acid lessens NK cell action against oncolytic virus-infected glioblastoma cells by inhibition of STAT5/T-BET signaling and generation of gamma interferon.Inactivated probiotic Bacillus coagulans GBI-30 induces complex immune activating, anti-inflammatory, and regenerative markers in vitro.Decrease of CD69 levels on TCR Vα7.2+CD4+ innate-like lymphocytes is associated with impaired cytotoxic functions in chronic hepatitis B virus-infected patients.KIR down-regulation on NK cells is associated with down-regulation of activating receptors and NK cell inactivation.
P2860
Q22010576-C0F5B94B-ED25-471B-9F42-E62D7B668B3CQ24310589-539203DA-D187-490D-8E9A-4BE14BAAB79DQ24310824-337FB51B-2451-4F12-94F9-C5FE6F797E86Q24318464-708480AB-5B5B-4BAA-8A94-D805B49816EDQ24647094-8ECEFB90-6C8E-4D02-B501-BB0346E4A1EFQ24647847-5C6CF74A-B8CC-4608-85EC-A52B827B0577Q24671834-4DCEE221-9836-424F-B552-D9952E823A05Q24795796-B571EB60-6B27-4BE8-BA7C-0781A4EA8196Q27001661-7E7E00E8-B19E-40C5-BC2F-C24AEB0A30E7Q27652690-483A79F8-13D5-499B-865C-2E99B9C82492Q28610853-3FA34182-6EAB-4AC0-A2C0-F7EEA4554B69Q30389411-EABC9EF1-5EA7-49CE-B7EF-870E5E6321F5Q33721814-3681B834-661B-43F1-BAA3-F7B3586D4740Q33854427-CAC6FAD2-0ADA-40E2-A7A3-AF6DDED8250CQ33894477-F92FB1AF-A4A0-4131-A526-98F0D729E21CQ34076485-F96D64D6-D8BE-4D41-B6FC-DA7877341EA3Q34304526-9F70DD0B-9AE5-42A8-8C7A-A36065A4401BQ34451498-3FBB79CA-9D81-42EC-84D3-372E05E9C124Q34586486-D00D675B-37E3-4007-86CC-D2BC220B5CC2Q35066122-4F02311B-91C6-40E3-B3B3-0510DB127180Q35487366-8A525447-3A94-42D6-BC3A-218C239561E5Q35609260-84D80E91-321C-4A11-B015-BEF25EA331F2Q35885104-28C86219-4C43-4571-97A9-A0F30C06980FQ36086345-0591BE0D-ED6D-4770-AFF9-EDB6DB4474BBQ36158192-D36F574B-E7FB-4ACA-927E-2AF5269B4F4BQ36309917-A0B70C08-B589-45EE-B6D4-FE6DD202B89EQ36370985-A292A013-5E7C-42D5-90AA-2DD5109837C0Q36399476-181F9A13-CFE8-4CE4-8358-6E5C3E5E40ECQ36421628-B09F7F67-D358-4002-8333-5F00C97692E1Q36497532-D8B3B125-3DDB-445E-B255-0D2338440340Q37469815-66F9F349-3344-4B08-8D37-DDF9BAA28B81Q37552129-3F06C3F4-DBD5-4A0D-B74E-DD310F884983Q37678862-CE3EF696-5497-478F-AE79-00B8016D4E37Q38174604-B81CE60D-CE30-4816-BBD4-0E839A6A7B7BQ38787754-00891F27-C6AE-4DB3-9C6E-224F1F1D5DC0Q39298834-816E54F2-232D-4EC7-8087-4C0815BA149EQ39399591-9547F0BA-2132-42F1-B1AA-CA6C208665FAQ40067231-644A485E-300E-43C2-A651-C550C0F270DBQ40163118-2502B924-A5D6-4608-BA6B-7225755D4C11Q40802002-972F6532-7712-4D15-81DA-DB1F685815B7
P2860
CD69-mediated pathway of lymphocyte activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor alpha/beta.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh
1991年學術文章
@zh-hant
name
CD69-mediated pathway of lymph ...... ng T cell receptor alpha/beta.
@en
CD69-mediated pathway of lymph ...... ng T cell receptor alpha/beta.
@nl
type
label
CD69-mediated pathway of lymph ...... ng T cell receptor alpha/beta.
@en
CD69-mediated pathway of lymph ...... ng T cell receptor alpha/beta.
@nl
prefLabel
CD69-mediated pathway of lymph ...... ng T cell receptor alpha/beta.
@en
CD69-mediated pathway of lymph ...... ng T cell receptor alpha/beta.
@nl
P2093
P2860
P356
P1476
CD69-mediated pathway of lymph ...... ng T cell receptor alpha/beta.
@en
P2093
Augugliaro R
P2860
P304
P356
10.1084/JEM.174.6.1393
P407
P577
1991-12-01T00:00:00Z